7-ethyl-10-hydroxycamptothecin Completed Phase 2 Trials for Small Cell Lung Cancer (SCLC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00951613A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer